Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy.

[1]  L. Jaacks,et al.  Silent myocardial ischemia detected by single photon emission computed tomography (SPECT) and risk of cardiac events among asymptomatic patients with type 2 diabetes: a meta-analysis of prospective studies. , 2014, Journal of diabetes and its complications.

[2]  F. Wolf,et al.  Standards of Medical Care in Diabetes—2016 Abridged for Primary Care Providers , 2016, Clinical Diabetes.

[3]  M. Zellweger,et al.  Prevalence, extent, and independent predictors of silent myocardial infarction. , 2013, The American journal of medicine.

[4]  T. Marwick,et al.  Impact of repeat myocardial revascularization on outcome in patients with silent ischemia after previous revascularization. , 2013, Journal of the American College of Cardiology.

[5]  J. Hochman,et al.  Revascularization for silent ischemia?: another piece of the puzzle. , 2013, Journal of the American College of Cardiology.

[6]  Fred S Apple,et al.  Third universal definition of myocardial infarction , 2012 .

[7]  Jennifer Taylor.  Third universal definition of myocardial infarction. , 2012, European heart journal.

[8]  M. Pfisterer,et al.  Coronary artery disease progression late after successful stent implantation. , 2012, Journal of the American College of Cardiology.

[9]  M. Zellweger,et al.  Diabetes reduces left ventricular ejection fraction--irrespective of presence and extent of coronary artery disease. , 2011, European journal of endocrinology.

[10]  V. Rigalleau,et al.  Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening , 2011, Trials.

[11]  L. Young,et al.  Lessons learned from the detection of ischemia in asymptomatic diabetics (DIAD) study , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[12]  Maria Mori Brooks,et al.  A randomized trial of therapies for type 2 diabetes and coronary artery disease. , 2009, The New England journal of medicine.

[13]  E. Barrett,et al.  Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. , 2009, JAMA.

[14]  Guido Germano,et al.  Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2008, Circulation.

[15]  A. Schoenenberger,et al.  Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study. , 2007, European heart journal.

[16]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[17]  R. Gibbons,et al.  Improved Survival in Asymptomatic Diabetic Patients With High-Risk Spect Imaging Treated With Coronary Artery Bypass Grafting , 2005, Circulation.

[18]  E. Barrett,et al.  Erratum: Detection of Ischemia in Asymptomatic Diabetics (DIAD) investigators: Detection of silent myocardial ischemia in asymptomatic diabetic subjects: The DIAD study (Diabetes Care (2004) 27 (1954-1961)) , 2005 .

[19]  E. Barrett,et al.  Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. , 2004, Diabetes care.

[20]  Daniel S. Berman,et al.  Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion spect interpretation , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[21]  E. Antman,et al.  ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl , 2003, Journal of the American College of Cardiology.

[22]  E. Antman,et al.  ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl , 2003, Journal of the American College of Cardiology.

[23]  D. Berman,et al.  Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? , 2003, Journal of the American College of Cardiology.

[24]  M. Rutter,et al.  Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes. , 2002, Journal of the American College of Cardiology.

[25]  The Time Investigators.  Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial , 2001, The Lancet.

[26]  M. Pfisterer,et al.  Silent coronary artery disease in patients with diabetes mellitus. , 2001, Swiss medical weekly.

[27]  Consensus Development Conference on the Diagnosis of Coronary Heart Disease in People With Diabetes: 10–11 February 1998, Miami, Florida , 1998, Diabetes Care.

[28]  N. Geller,et al.  Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. , 1997, Circulation.

[29]  D. Ewing,et al.  The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes , 1985, Diabetes Care.

[30]  J. Alpert,et al.  Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction , 2008 .

[31]  Bengt Jönsson,et al.  [Guidelines on diabetes, pre-diabetes, and cardiovascular diseases]. , 2007, Revista espanola de cardiologia.

[32]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .

[33]  D. Berman,et al.  Risk stratification in patients with remote prior myocardial infarction using rest-stress myocardial perfusion spect: prognostic value and impact on referral to early catheterization , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.